GER-009-06-AVX Early Therapy in Multiple Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study is being done to increase awareness for early therapy with Avonex for Multiple Sclerosis (MS) and the cognitive dysfunction that accompanies MS, and to record safety data for Avonex.
Epistemonikos ID: c2f04533936cbea4707c61ced2437ba97b208b03
First added on: May 04, 2024